Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Patent Foramen Ovale Closure or Anticoagulants Versus Antiplatelet Therapy to Prevent Stroke Recurrence (CLOSE)
The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2007
by Assistance Publique - Hôpitaux de Paris.
Recruitment status was Recruiting
Study NCT00562289 Information provided by Assistance Publique - Hôpitaux de Paris
First Received on November 21, 2007. Last Updated on December 11, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Ischemic Stroke
Patent Foramen Ovale
Atrial Septal Aneurysm
Migraine
Additional conditions recognized in this trial
Aneurysm
Cerebral Infarction
Foramen Ovale, Patent
Heart Septal Defects, Atrial
Migraine Disorders
Recurrence
Stroke
More general conditions related to this trial
Brain Diseases
Brain Infarction
Brain Ischemia
Cardiovascular Abnormalities
Cardiovascular Diseases
Central Nervous System Diseases
Cerebrovascular Disorders
Congenital Abnormalities
Disease Attributes
Headache Disorders
Headache Disorders, Primary
Heart Defects, Congenital
Heart Diseases
Heart Septal Defects
Nervous System Diseases
Pathologic Processes
Vascular Diseases
Interventions listed in this trial
aspirin
Antivitamins K
Devices for PFO closure
Additional drug interventions recognized in this trial
4-Hydroxycoumarins
Anticoagulants
Aspirin, dipyridamole drug combination
Dipyridamole
Vitamin K
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antifibrinolytic Agents
Antipyretics
Antirheumatic Agents
Cardiovascular Agents
Central Nervous System Agents
Coagulants
Cyclooxygenase Inhibitors
Enzyme Inhibitors
Fibrin Modulating Agents
Fibrinolytic Agents
Growth Substances
Hematologic Agents
Hemostatics
Micronutrients
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Phosphodiesterase Inhibitors
Physiological Effects of Drugs
Platelet Aggregation Inhibitors
Sensory System Agents
Therapeutic Uses
Vasodilator Agents
Vitamins
Sponsors listed in this trial
Assistance Publique - Hôpitaux de Paris
Back to top of Main Content
